Target intelligence / Profile preview

Mucin-type O-glycan glycosidic linkage

Molecular classification
Other
01

Overview

Glycosidic linkages in mucin oligosaccharide chains are the covalent bonds that anchor complex O-glycans to the protein core of mucins, primarily through N-acetylgalactosamine (GalNAc) attached to serine or threonine residues [1]. These linkages are fundamental to the structural integrity and physicochemical properties of mucus, which serves as a critical protective barrier for epithelial surfaces in the respiratory, gastrointestinal, and urogenital tracts [1]. Biologically, the dense clusters of these O-glycans create a 'bottle-brush' conformation that allows mucins to retain water and provide lubrication. In various diseases, particularly epithelial cancers, these linkages are altered by the dysregulation of glycosyltransferases, resulting in truncated glycan structures like the Tn and Sialyl-Tn antigens [3]. These aberrant structures facilitate tumor progression, immune evasion, and metastasis by altering cell-cell interactions and signaling. While most clinical mucolytics target disulfide bridges, agents such as bromhexine and ambroxol are described as acting on these glycosidic structures by stimulating lysosomal activity to depolymerize mucopolysaccharide fibers [2]. Consequently, these linkages represent a focal point for understanding mucus rheology and developing targeted glycan-based therapies or diagnostics in oncology and chronic inflammatory airway diseases [3].

Other names
Glycosidic linkages in mucin oligosaccharide chainsMucin O-glycansO-linked oligosaccharidesMucin-type O-glycosylationAcid mucopolysaccharide fibers
02

Mechanism of action

Depolymerization of mucopolysaccharide fibers through the stimulation of lysosomal enzymes that hydrolyze glycosidic bonds.

03

Biological functions

Other
04

Disease associations

CancerInfectionOther
05

Safety considerations

Gastric mucosal irritationHypersensitivity reactionsDisruption of protective mucus barrier
06

Interacting drugs

Bromhexine

2 more in the full profile.

07

Biomarkers

Sialyl-Tn antigen (STn)Tn antigenCancer Antigen 15-3 (CA 15-3)TAG-72

Beyond the preview

Go deeper on Mucin-type O-glycan glycosidic linkage.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mucin-type O-glycan glycosidic linkage.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call